Breaking News Instant updates and real-time market news.

ADPT

Adaptive Biotechnologies

$35.38 /

-2.38 (-6.30%)

, JNJ

Johnson & Johnson

$163.42 /

-1.42 (-0.86%)

07:55
06/09/21
06/09
07:55
06/09/21
07:55

Adaptive Biotechnologies publishes data on COVID-19 vaccine, T-Cell response

Adaptive Biotechnologies (ADPT) announced that immunoSEQ T-MAP COVID was used in the Nature study to measure the T-cell immune response elicited by the Johnson & Johnson (JNJ) COVID-19 vaccine in the context of multiple variants of SARS-CoV-2, including B 1.351 and B.1.1.7. The study provides further evidence that the T-cell response may contribute to protection from COVID-19. Adaptive's Technology was used to quantify T-cell expansion across all regions of the virus, demonstrating that the T-cell response is broad and unaltered by mutations that render vaccine-generated antibodies less effective. In the multinational phase 3 ENSEMBLE trial, participants given Johnson & Johnson's vaccine experienced similar efficacy against the B.1.351 variant. To understand the mechanism of protection, the COV1001 phase 1/2 trial analyzed blood samples from 20 vaccinated individuals to measure antibody immune response and T-cell response against the original SARS-CoV-2 strain WA1/2020 as well as against the B.1.1.7, CAL.20C, P.1., and B.1.351 variants. Post-vaccination, results showed that the levels of neutralizing antibodies were diminished against the variants, but that the T-cell immune response was preserved, suggesting T cells may provide protection against these emerging strains. Results indicate T-cells may be an important correlate of protection and should be considered as an endpoint for vaccine clinical trials.

ADPT

Adaptive Biotechnologies

$35.38 /

-2.38 (-6.30%)

JNJ

Johnson & Johnson

$163.42 /

-1.42 (-0.86%)

  • 11

    Jun

  • 23

    Jun

  • 21

    Jul

  • 16

    Jul

ADPT Adaptive Biotechnologies
$35.38 /

-2.38 (-6.30%)

03/03/21
Fly Intel: Top five analyst downgrades
03/03/21 Goldman Sachs
Adaptive Biotechnologies downgraded to Neutral from Buy at Goldman Sachs
01/19/21 BTIG
Adaptive Biotechnologies price target raised to $74 from $66 at BTIG
12/17/20 BTIG
BTIG positive on select healthcare diagnostic/tools names as '2021 Top Picks'
JNJ Johnson & Johnson
$163.42 /

-1.42 (-0.86%)

06/08/21 Wedbush
Argenx price target lowered to $344 from $356 at Wedbush
06/08/21 Baird
Argenx price target lowered to $333 from $346 at Baird
06/07/21 BofA
BofA upgrades Biogen to Neutral with $400 price target after Aduhelm approved
06/02/21 Jefferies
Legend Biotech cilta-cel PFS rate 'largely exceeds' expectation, says Jefferies

TODAY'S FREE FLY STORIES

Recommendations
Braemar Hotels & Resorts price target raised to $10 from $9 at B. Riley » 07:56
06/15/21
06/15
07:56
06/15/21
07:56
BHR

Braemar Hotels & Resorts

$6.42 /

-0.145 (-2.21%)

B. Riley analyst Bryan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BHR Braemar Hotels & Resorts
$6.42 /

-0.145 (-2.21%)

BHR Braemar Hotels & Resorts
$6.42 /

-0.145 (-2.21%)

04/26/21 B. Riley
Braemar Hotels & Resorts upgraded to Buy from Neutral at B. Riley
03/04/21 B. Riley Securities
Braemar Hotels & Resorts price target raised to $6.50 from $5 at B. Riley
03/04/21 Deutsche Bank
Braemar Hotels & Resorts price target raised to $12 from $10 at Deutsche Bank
12/02/20 B. Riley Securities
Braemar Hotels & Resorts price target raised to $5 from $4 at B. Riley
BHR Braemar Hotels & Resorts
$6.42 /

-0.145 (-2.21%)

Upgrade
PerkinElmer upgraded to Outperform from Peer Perform at Wolfe Research » 07:52
06/15/21
06/15
07:52
06/15/21
07:52
PKI

PerkinElmer

$147.13 /

+0.3 (+0.20%)

Wolfe Research analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PKI PerkinElmer
$147.13 /

+0.3 (+0.20%)

PKI PerkinElmer
$147.13 /

+0.3 (+0.20%)

02/03/21 Citi
PerkinElmer price target raised to $155 from $150 at Citi
01/07/21 Piper Sandler
Oxford Immunotec downgraded to Neutral from Overweight at Piper Sandler
01/07/21 Wells Fargo
PerkinElmer upgraded to Overweight from Equal Weight at Wells Fargo
01/07/21 Wells Fargo
PerkinElmer upgraded to Overweight from Equal Weight at Wells Fargo
PKI PerkinElmer
$147.13 /

+0.3 (+0.20%)

PKI PerkinElmer
$147.13 /

+0.3 (+0.20%)

PKI PerkinElmer
$147.13 /

+0.3 (+0.20%)

Recommendations
Healthpeak price target raised to $39 from $34 at Argus » 07:51
06/15/21
06/15
07:51
06/15/21
07:51
PEAK

Healthpeak

$35.29 /

+0.52 (+1.50%)

Argus analyst Angus…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PEAK Healthpeak
$35.29 /

+0.52 (+1.50%)

05/20/21
Fly Intel: Top five analyst downgrades
05/20/21 Berenberg
Healthpeak upgraded to Buy from Hold at Berenberg
05/20/21 JPMorgan
Healthpeak downgraded to Neutral on valuation at JPMorgan
05/20/21 JPMorgan
Healthpeak downgraded to Neutral from Overweight at JPMorgan
PEAK Healthpeak
$35.29 /

+0.52 (+1.50%)

Recommendations
Ventas price target raised to $65 from $61 at Raymond James » 07:50
06/15/21
06/15
07:50
06/15/21
07:50
VTR

Ventas

$58.95 /

+0.83 (+1.43%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VTR Ventas
$58.95 /

+0.83 (+1.43%)

VTR Ventas
$58.95 /

+0.83 (+1.43%)

06/14/21 Wolfe Research
Ventas initiated with an Outperform at Wolfe Research
06/11/21 Barclays
Ventas upgraded to Overweight from Equal Weight at Barclays
06/03/21 Deutsche Bank
Ventas price target raised to $61 from $50 at Deutsche Bank
05/25/21 Raymond James
Ventas price target raised to $61 from $54 at Raymond James
VTR Ventas
$58.95 /

+0.83 (+1.43%)

General news
Treasury Market Outlook: Treasuries are little changed but mostly firmer » 07:50
06/15/21
06/15
07:50
06/15/21
07:50
$ECON

Economic Data

/

+

Treasury Market Outlook:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

Upgrade
Raymond James upgrades Welltower to Strong Buy on 'multiyear cycle' » 07:49
06/15/21
06/15
07:49
06/15/21
07:49
WELL

Welltower

$81.22 /

+1.7 (+2.14%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WELL Welltower
$81.22 /

+1.7 (+2.14%)

WELL Welltower
$81.22 /

+1.7 (+2.14%)

06:24 Today Raymond James
Welltower upgraded to Strong Buy from Market Perform at Raymond James
06/14/21 Wolfe Research
Welltower initiated with an Outperform at Wolfe Research
06/14/21
Fly Intel: Top five analyst upgrades
06/14/21 Evercore ISI
Welltower upgraded to Outperform from In Line at Evercore ISI
WELL Welltower
$81.22 /

+1.7 (+2.14%)

WELL Welltower
$81.22 /

+1.7 (+2.14%)

Recommendations
Wells Fargo price target raised to $52 from $50 at Raymond James » 07:49
06/15/21
06/15
07:49
06/15/21
07:49
WFC

Wells Fargo

$45.15 /

-0.53 (-1.16%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WFC Wells Fargo
$45.15 /

-0.53 (-1.16%)

WFC Wells Fargo
$45.15 /

-0.53 (-1.16%)

06/04/21
Fly Intel: Top five analyst upgrades
06/04/21 BofA
BofA upgrades Wells Fargo to Buy amid 'multi-year transformation'
06/04/21 BofA
Wells Fargo upgraded to Buy from Neutral at BofA
05/19/21
Fly Intel: Top five analyst downgrades
WFC Wells Fargo
$45.15 /

-0.53 (-1.16%)

WFC Wells Fargo
$45.15 /

-0.53 (-1.16%)

WFC Wells Fargo
$45.15 /

-0.53 (-1.16%)

WFC Wells Fargo
$45.15 /

-0.53 (-1.16%)

Hot Stocks
Field Trip Health announces completion of DMPK studies for FT-104 » 07:47
06/15/21
06/15
07:47
06/15/21
07:47
FTRPF

Field Trip Health

$5.31 /

+0.11 (+2.12%)

Field Trip Health…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FTRPF Field Trip Health
$5.31 /

+0.11 (+2.12%)

FTRPF Field Trip Health
$5.31 /

+0.11 (+2.12%)

02/18/21 Stifel
Field Trip Health price target raised to C$10 from C$8.50 at Stifel
01/14/21 Stifel
Field Trip Health initiated with a Speculative Buy at Stifel
Initiation
Aiful initiated with a Buy at Jefferies » 07:46
06/15/21
06/15
07:46
06/15/21
07:46
AIFLY

Aiful

$1.65 /

+ (+0.00%)

Jefferies analyst Hiro…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Upgrade
Finance of America upgraded to Strong Buy from Outperform at Raymond James » 07:46
06/15/21
06/15
07:46
06/15/21
07:46
FOA

Finance of America

$7.30 /

-0.64 (-8.06%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FOA Finance of America
$7.30 /

-0.64 (-8.06%)

FOA Finance of America
$7.30 /

-0.64 (-8.06%)

06:26 Today Raymond James
Finance of America upgraded to Strong Buy from Outperform at Raymond James
04/23/21 Raymond James
First of America initiated with an Outperform at Raymond James
04/23/21 Raymond James
First of America initiated with an Outperform at Raymond James
FOA Finance of America
$7.30 /

-0.64 (-8.06%)

Initiation
Lument Finance Trust initiated with an Outperform at Raymond James » 07:44
06/15/21
06/15
07:44
06/15/21
07:44
LFT

Lument Finance Trust

$4.21 /

+0.155 (+3.82%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LFT Lument Finance Trust
$4.21 /

+0.155 (+3.82%)

06:33 Today Raymond James
Lument Finance Trust initiated with an Outperform at Raymond James
02/05/21 JonesTrading
Lument Finance Trust initiated with a Buy at JonesTrading
LFT Lument Finance Trust
$4.21 /

+0.155 (+3.82%)

LFT Lument Finance Trust
$4.21 /

+0.155 (+3.82%)

Initiation
Dentalcorp initiated with a Buy at Jefferies » 07:44
06/15/21
06/15
07:44
06/15/21
07:44
DNTL.TO

Dentalcorp

/

+

Jefferies analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DNTL.TO Dentalcorp
/

+

05:05 Today CIBC
Dentalcorp initiated with an Outperformer at CIBC
04:44 Today BMO Capital
Dentalcorp initiated with an Outperform at BMO Capital
Initiation
Myriad Genetics initiated with a Market Perform at Raymond James » 07:42
06/15/21
06/15
07:42
06/15/21
07:42
MYGN

Myriad Genetics

$29.92 /

+0.21 (+0.71%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MYGN Myriad Genetics
$29.92 /

+0.21 (+0.71%)

MYGN Myriad Genetics
$29.92 /

+0.21 (+0.71%)

06/03/21 Goldman Sachs
Myriad Genetics initiated with a Sell at Goldman Sachs
05/03/21 William Blair
LabCorp's Vectra deal likely not the last for this year, says William Blair
02/24/21 SVB Leerink
Myriad Genetics price target raised to $33 from $20 at SVB Leerink
11/10/20 Piper Sandler
Myriad Genetics price target raised to $18 from $14 at Piper Sandler
MYGN Myriad Genetics
$29.92 /

+0.21 (+0.71%)

MYGN Myriad Genetics
$29.92 /

+0.21 (+0.71%)

MYGN Myriad Genetics
$29.92 /

+0.21 (+0.71%)

Initiation
Natura initiated with a Buy at Jefferies » 07:42
06/15/21
06/15
07:42
06/15/21
07:42
NTCO

Natura

/

+

Jefferies analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NTCO Natura
/

+

06/11/21 Goldman Sachs
Natura upgraded to Neutral from Sell at Goldman Sachs
  • 09
    Oct
Upgrade
Crane upgraded to Buy at DA Davidson following Engineered Materials divestment » 07:42
06/15/21
06/15
07:42
06/15/21
07:42
CR

Crane

$90.81 /

-1.26 (-1.37%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CR Crane
$90.81 /

-1.26 (-1.37%)

CR Crane
$90.81 /

-1.26 (-1.37%)

06:37 Today DA Davidson
Crane upgraded to Buy from Neutral at DA Davidson
05/05/21 DA Davidson
Crane price target raised to $105 from $85 at DA Davidson
03/08/21 Canaccord
Crane price target raised to $100 from $96 at Canaccord
01/07/21 Vertical Research
Crane upgraded to Buy with $97 price target at Vertical Research
CR Crane
$90.81 /

-1.26 (-1.37%)

CR Crane
$90.81 /

-1.26 (-1.37%)

CR Crane
$90.81 /

-1.26 (-1.37%)

Hot Stocks
SPAR Group announces resignation of three independent board members » 07:41
06/15/21
06/15
07:41
06/15/21
07:41
SGRP

SPAR Group

$1.52 /

+0.03 (+2.01%)

SPAR Group announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SGRP SPAR Group
$1.52 /

+0.03 (+2.01%)

SGRP SPAR Group
$1.52 /

+0.03 (+2.01%)

Initiation
Guardant Health initiated with a Market Perform at Raymond James » 07:41
06/15/21
06/15
07:41
06/15/21
07:41
GH

Guardant Health

$123.75 /

+2.83 (+2.34%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GH Guardant Health
$123.75 /

+2.83 (+2.34%)

GH Guardant Health
$123.75 /

+2.83 (+2.34%)

06/03/21
Fly Intel: Top five analyst initiations
06/03/21 Goldman Sachs
Guardant Health initiated with a Buy at Goldman Sachs
05/25/21 Wells Fargo
Guardant Health initiated with an Overweight at Wells Fargo
02/25/21 Cowen
Guardant Health price target raised to $190 from $140 at Cowen
GH Guardant Health
$123.75 /

+2.83 (+2.34%)

  • 07
    Oct
GH Guardant Health
$123.75 /

+2.83 (+2.34%)

Hot Stocks
Cannon Air Force Base partners with Ameresco for $19M cleantech project » 07:40
06/15/21
06/15
07:40
06/15/21
07:40
AMRC

Ameresco

$61.05 /

+1.47 (+2.47%)

Ameresco announced its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMRC Ameresco
$61.05 /

+1.47 (+2.47%)

AMRC Ameresco
$61.05 /

+1.47 (+2.47%)

04/07/21 Stifel
Ameresco initiated with a Buy at Stifel
04/07/21
Fly Intel: Top five analyst initiations
04/07/21 William Blair
Ameresco initiated with an Outperform at William Blair
03/25/21 Baird
Ameresco initiated with an Outperform at Baird
AMRC Ameresco
$61.05 /

+1.47 (+2.47%)

  • 05
    Mar
AMRC Ameresco
$61.05 /

+1.47 (+2.47%)

Hot Stocks
Capital One reports May net charge-offs 2.33% » 07:39
06/15/21
06/15
07:39
06/15/21
07:39
COF

Capital One

$158.72 /

-1.97 (-1.23%)

Reports May 30-plus day…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
COF Capital One
$158.72 /

-1.97 (-1.23%)

COF Capital One
$158.72 /

-1.97 (-1.23%)

06/07/21
Fly Intel: Top five analyst downgrades
06/07/21 Baird
Capital One downgraded to Neutral after 68% rally at Baird
06/07/21 Baird
Capital One downgraded to Neutral from Outperform at Baird
04/29/21 Deutsche Bank
Capital One price target raised to $170 from $135 at Deutsche Bank
COF Capital One
$158.72 /

-1.97 (-1.23%)

COF Capital One
$158.72 /

-1.97 (-1.23%)

COF Capital One
$158.72 /

-1.97 (-1.23%)

Hot Stocks
Vision Marine Technologies partners with Hellkats, Center Console Only » 07:39
06/15/21
06/15
07:39
06/15/21
07:39
VMAR

Vision Marine Technologies

$11.02 /

-0.56 (-4.84%)

Vision Marine…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VMAR Vision Marine Technologies
$11.02 /

-0.56 (-4.84%)

VMAR Vision Marine Technologies
$11.02 /

-0.56 (-4.84%)

01/11/21 ThinkEquity
Vision Marine Technologies initiated with a Buy at ThinkEquity
  • 24
    Nov
Initiation
Natera initiated with a Market Perform at Raymond James » 07:39
06/15/21
06/15
07:39
06/15/21
07:39
NTRA

Natera

$103.85 /

-0.04 (-0.04%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NTRA Natera
$103.85 /

-0.04 (-0.04%)

NTRA Natera
$103.85 /

-0.04 (-0.04%)

06/01/21 Baird
Natera elevated to bullish Fresh Pick at Baird
05/26/21 Piper Sandler
Investors overlook positive trends at Natera, says Piper Sandler
05/25/21 Truist
Natera price target lowered to $129 from $143 at Truist
05/25/21 Wells Fargo
Natera initiated with an Overweight at Wells Fargo
NTRA Natera
$103.85 /

-0.04 (-0.04%)

  • 11
    Sep
NTRA Natera
$103.85 /

-0.04 (-0.04%)

Initiation
Invitae initiated with an Outperform at Raymond James » 07:38
06/15/21
06/15
07:38
06/15/21
07:38
NVTA

Invitae

$31.50 /

+0.31 (+0.99%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVTA Invitae
$31.50 /

+0.31 (+0.99%)

NVTA Invitae
$31.50 /

+0.31 (+0.99%)

06:34 Today Raymond James
Invitae initiated with an Outperform at Raymond James
06/03/21 Goldman Sachs
Invitae initiated with a Neutral at Goldman Sachs
05/25/21 Wells Fargo
Invitae initiated with an Equal Weight at Wells Fargo
04/05/21 Oppenheimer
Oppenheimer upgrades Invitae on valuation, sees potential high $50s stock
NVTA Invitae
$31.50 /

+0.31 (+0.99%)

  • 22
    Jan
NVTA Invitae
$31.50 /

+0.31 (+0.99%)

Hot Stocks
NRx Pharma reports data from ZYESAMI EAP » 07:37
06/15/21
06/15
07:37
06/15/21
07:37
NRXP

NRx Pharmaceuticals

$18.01 /

-0.69 (-3.69%)

NRx Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NRXP NRx Pharmaceuticals
$18.01 /

-0.69 (-3.69%)

Recommendations
Eli Lilly price target raised to $260 from $240 at JPMorgan » 07:37
06/15/21
06/15
07:37
06/15/21
07:37
LLY

Eli Lilly

$226.10 /

+1.95 (+0.87%)

, BIIB

Biogen

$406.03 /

+9.57 (+2.41%)

JPMorgan analyst Chris…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LLY Eli Lilly
$226.10 /

+1.95 (+0.87%)

BIIB Biogen
$406.03 /

+9.57 (+2.41%)

LLY Eli Lilly
$226.10 /

+1.95 (+0.87%)

06/14/21 Goldman Sachs
Eli Lilly price target raised to $270 from $252 at Goldman Sachs
06/08/21 Baird
Baird upgrades Biogen to Neutral after 'fatal blow' to bear thesis
06/07/21 BofA
BofA upgrades Biogen to Neutral with $400 price target after Aduhelm approved
05/27/21 H.C. Wainwright
H.C. Wainwright bullish on Dicerna as new RNAi candidate enters clinic
BIIB Biogen
$406.03 /

+9.57 (+2.41%)

06:20 Today Citi
Prothena price target raised to $57 from $39 at Citi
06/14/21 Truist
Biogen price target raised to $647 from $458 at Truist
06/14/21 Goldman Sachs
Eli Lilly price target raised to $270 from $252 at Goldman Sachs
06/14/21 Goldman Sachs
Biogen price target raised to $436 from $246 at Goldman Sachs
LLY Eli Lilly
$226.10 /

+1.95 (+0.87%)

BIIB Biogen
$406.03 /

+9.57 (+2.41%)

LLY Eli Lilly
$226.10 /

+1.95 (+0.87%)

BIIB Biogen
$406.03 /

+9.57 (+2.41%)

LLY Eli Lilly
$226.10 /

+1.95 (+0.87%)

BIIB Biogen
$406.03 /

+9.57 (+2.41%)

LLY Eli Lilly
$226.10 /

+1.95 (+0.87%)

BIIB Biogen
$406.03 /

+9.57 (+2.41%)

Hot Stocks
Salarius Pharmaceuticals announces new clinical trial to study seclidemstat » 07:37
06/15/21
06/15
07:37
06/15/21
07:37
SLRX

Salarius Pharmaceuticals

$1.22 /

+0.045 (+3.83%)

Salarius Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SLRX Salarius Pharmaceuticals
$1.22 /

+0.045 (+3.83%)

SLRX Salarius Pharmaceuticals
$1.22 /

+0.045 (+3.83%)

06/16/20 Benchmark
Salarius Pharmaceuticals initiated with a Speculative Buy at Benchmark
  • 04
    Mar
  • 30
    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.